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Abstract
Complex wounds are common complications in hospice and palliative medicine (HPM), especially in patients
with aggressive malignancies. Myiasis, or an infestation of maggots, is a rare but significant complication of such
wounds. While uncommon in the United States, many HPM patients have multiple risk factors and comorbidities
that increase their vulnerability to this condition. Currently, there are no standard diagnostic or treatment
guidelines for wound myiasis. In addition, common management strategies may not be easily accessible in HPM
settings. We present this case of a patient with malignant squamous cell carcinoma of the neck complicated by
myiasis while in hospice, and our experience diagnosing and managing her infestation. We also reflect on special
considerations for HPM patients when addressing the physical and psychological symptoms of wound myiasis.
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Introduction
Hospice and palliative medicine (HPM) providersoften encounter patients with complex wounds. These
wounds are related to various factors including poor nutri-
tion, physical debility, malignancy, and other comorbidities
that can make wound management challenging. Palliative
management of the complications of such wounds often re-
quires an interdisciplinary approach.1
Myiasis is a rare complication of malignant wounds. It is
characterized by infestation of open wounds by fly larvae.2
Although myiasis is most prevalent in tropical and subtropical
regions, its occurrence has been increasingly well documented
in other areas, including Europe and North America.3
Patients with complex wounds, particularly those related
to malignancies, are at risk of wound myiasis. The infestation
can be distressing for both patients and caregivers, and has a
significant impact on quality of life.4 Little has been written
about the management of wound myiasis in the HPM setting.
Here, we present the case of a hospice patient who developed
myiasis of a complex malignant wound and our management
of her condition.
Case Description
RT is a 62-year-old woman with locally invasive squa-
mous cell carcinoma of the left neck. At the time of diagnosis,
the patient was recommended to undergo surgical resection
followed by radiation and chemotherapy with curative intent.
However, the patient had a lifelong aversion to conventional
medical practices and opted to pursue homeopathic treat-
ments for her cancer. She was lost to follow-up until three
years later when she presented with profuse bleeding from the
neck tumor, by then *8 cm by 10 cm. The mass had necrotic
areas along with a foul odor concerning for infection. Ima-
ging showed evidence of local spread to several neighboring
large vessels.
During her hospitalization, RT successfully underwent an
embolization procedure to reduce the bleeding. She was
deemed not to be a surgical candidate due to the extent of
her disease and again declined radiation or chemotherapy.
After much discussion with the patient and her family, she
was enrolled in hospice care at a local inpatient hospice
facility.
On arrival to hospice, RT was ambulatory and fully alert.
She continued to self-administer homeopathic therapies,
which consisted of a variety of vitamin supplements and
glutathione. Her wound care included daily dressing chan-
ges with a Vaseline base and gauze, which she preferred to
do herself due to concerns for rebleeding with occasional
assistance from nursing. Despite the extent of her cancer,
she enjoyed taking walks outside in the gardens of the
hospice facility as an important part of her physical and
spiritual care plan.
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Approximately four weeks after RT’s admission to hos-
pice, her nurse noticed a maggot fall out of the patient’s neck
dressing. Removal of the dressing revealed numerous mag-
gots in and around her tumor. On evaluation by her hospice
physician, the patient denied worsening pain, fevers, or re-
current bleeding but did admit to not changing her dressing
for several days due to fears of bleeding. RT denied emo-
tional distress at seeing the maggots. She believed that since
maggots consume dead tissue, it meant that her tumor was
dying and her homeopathic treatment was effectively treating
her malignancy.
Discussion
There are few documented cases of wound myiasis in the
United States in HPM patient populations.5 Among HPM
patients, most myiasis literature originates from India, in-
cluding a 2004 study in which 71 patients with maggot in-
festations were recorded in one palliative center over six
years.4 Regardless of their country of origin, HPM patients
with complex wounds share risk factors that make them
vulnerable to myiasis, including advanced age, poor hygiene,
malnourishment, social isolation, and chronic diseases such
as diabetes, peripheral vascular disease, and psychiatric dis-
orders.6,7
Myiasis begins when flies oviposit into necrotic, purulent
lesions; wounds that release alkaline discharge (pH 7.1–
7.5) are especially attractive to flies.2,8 Wound myiasis is a
potential complication of head and neck cancers. In So-
wani’s 2004 study, 83% of the 71 patients with myiasis had
underlying head and neck cancer.4 In 2009, a literature
review showed that there were *20 published cases of
maggot infestations originating from malignant head and
neck wounds.9 It has even been suggested that patients with
head or neck myiasis should be biopsied for an underlying
malignancy.3 Head and neck cancer wounds are also often
harder to dress, which can increase the risk of exposure to
flies.
While the larvae removed from our patient were not sent
for species identification, the majority of wound myiasis
in the United States originates from flies of the Calli-
phodate family, which include Lucila sericata (green
bottle blow fly) and Phormia regina (black blow fly).10–12
For most patients, speciation in wound myiasis is largely
academic since treatment recommendations do not vary
with fly type.
While there are no standardized treatment guidelines for
myiasis, the consensus within the literature is that mechanical
removal of all larvae is required to eradicate the infestation.
Beyond this, occlusive techniques using various substances
including petrolatum, beeswax, paraffin, hair gel, and adhe-
sive tape have been described.5,11 In low-resource global
settings, bacon and animal fat have been successfully used as
an occlusive agent, which causes deeper larvae to migrate to
the surface for easier extraction.13 Intensive irrigation with
rinses of normal saline, aqueous chlorhexidine, hydrogen
peroxide, and turpentine oil has also been shown to help with
removal of tunneling larvae. Larvae can also be immobilized
by agents such as lidocaine or 15% chloroform mixed with
oil, to make removal easier.6,12,14 We believe that many of
the abovementioned management options are feasible in
most HPM settings.
Less commonly, treatment may include surgical de-
bridement of necrotic tissue in the case of an ulcerating or
fungating malignancy, though this is less applicable to
hospice populations given the relative invasive nature of
this treatment modality. Many HPM settings in the United
States have little routine exposure to myiasis and when
faced with an absence of standardized guidelines, Vill-
wock’s 2014 paper presents a useful treatment algorithm for
myiasis, which incorporates many of the strategies men-
tioned above.3
After removal of larvae, frequent dressing changes
and proper wound care are essential to preventing recur-
rent myiasis and superinfections. For our patient, infrequent
dressing changes in conjunction with spending time outdoors
were likely major contributors to the development of myiasis,
and our patient required regular dressing changes to prevent
recurrence until her decline. However, in patients suffering
from invasive head and neck malignancies, the risk of in-
fection must be balanced with the risk of bleeding and carotid
blowout, which may increase with frequent handling of
dressings.
Aside from the physical symptoms, myiasis can be dis-
figuring, and cause significant psychological distress and
disgust among patients and caregivers. Our patient’s con-
viction of the efficacy of homeopathic care and her hope that
the maggots would consume the malignant tissue caused her
to have an unusually positive response to the infestation.
However, for most patients, there is a significant negative
psychological impact associated with myiasis. Given the
stigma and visibility of maggot infestations, it is typical for
patients to report feelings of fear, distress, and isolation,
which are complicated by the physical symptoms of infes-
tation.4 Studies have shown improvement in well-being, de-
pression, and feelings of distress among myiasis patients after
completion of treatment.15 It is thus important to take into
consideration the psychological impact of a maggot infesta-
tion and have a multidisciplinary approach to management of
these patients, which involves physicians, nursing, social
work, chaplains, and therapists.
In addition to patient distress, there is often a component of
caregiver distress to myiasis.4 It is imperative, especially in
HPM populations, that caregivers are counseled and trained
in managing their own distress upon seeing larvae. It is also
important that patients and caregivers be given proper
training in wound cleaning, sanitation, and dressing changes
to avoid recurrence.
Myiasis itself can be a cause of death.16 In addition,
malignancies that have progressed to fungation, necrosis,
or ulceration are at increased risk of myiasis and are asso-
ciated with a worse prognosis.17,18 The most common
complication of myiasis is secondary bacterial infection.
Other complications include pneumocephalus, bony de-
struction, hemorrhage, and fistula formation.3,16 The risk of
certain adverse events may be elevated in malignant wound
myiasis; malignant fungating wounds provide optimal en-
vironments for bacterial growth, leading to an increased
risk of superinfection, especially in patients with cutaneous
metastases.9,15 Damage to the friable tissue and blood
vessels of terminal head and neck cancer can also lead
to hemorrhage.19 In addition, for patients with incurable
cancer, the primary underlying condition that promotes
infestation is maintained, predisposing the patient toward


















































reinfestation. However, with timely and complete treat-
ment these complications are preventable, and most pa-
tients recover from their infestation.
As with other conditions, careful consideration should be
paid to the relative burdens and benefits of treatment. In cases
where myiasis is nondistressing to the patient and family and
the patient has reached a stage of end of life where inter-
vention to the wound may cause more distress than benefit,
one can consider opting out of treatment. Our patient was not
experiencing the expected distress associated with myiasis,
but the risk of further complications was deemed to be suf-
ficient to warrant treatment.
Finally, wound myiasis is often a superficial sign indicat-
ing a deeper level of neglect and debility leading to insuffi-
cient wound care. However, in independent patients myiasis
may denote a choice in care that has practical, emotional,
cultural, or spiritual origins, as was our patient’s case. Dif-
ferentiating this from self-neglect requires careful examina-
tion of the patient’s history, and a thoughtful approach with
an interdisciplinary team including social work is essential to
providing support to adequately meet such a patient’s
evolving needs. Any concerns for neglect or abuse such as a
history of unsanitary living conditions, poor hygiene, or in-
adequate medical care warrant immediate reporting to pro-
tective services.
Case Resolution
Given the concern for superinfection and further bleeding
negatively impacting her quality of life, a goals-of-care
discussion with the patient and family was held after which
a shared decision was made to proceed with myiasis treat-
ment. The hospice physician contacted a local tertiary care
hospital, who put him in contact with a plastic surgeon
whose research involved parasitic wound infections; he
suggested occlusion with bacon or Vaseline as readily ac-
cessible therapeutic options. The hospice physician also
consulted the hospice pharmacist, who recommended gentle
irrigation with warm water. Because the larvae appeared to
be superficial and easily accessible on examination, the
provider opted to start with water irrigation to remove all
visible larvae. A kerlix dressing soaked in betadine solution
was then applied to the neck mass with each dressing
change. The betadine dressings were used for two weeks and
then stopped, after which the maggots returned though to a
much lesser degree than before. The betadine dressings
were restarted for an additional two weeks, after which the
maggots did not return.
During this time, the hospice interdisciplinary team in-
cluding the physician, nurse, social worker, and chaplain
worked to balance RT’s desire for control with her complex
wound needs. There were concerns for self-neglect, and so
much time was spent educating the patient on the impor-
tance of dressing changes to prevent infection. Nursing was
also more involved in her dressing changes, which RT
engaged with but would occasionally delay. Social work
suspected that in addition to her fear of rebleeding, there
was an element of denial as dressing changes forced her to
directly engage with her advanced cancer. However, the
team did not feel that a report to protective services for self-
neglect was warranted. RT remained compliant with
dressing changes and continued her alternative therapies
for her cancer. She continued a slow decline and passed
away at the hospice residence four months after her hospice
admission.
Conclusion
Cutaneous myiasis is a well-known complication of
necrotic malignant wounds; individuals suffering from
head and neck cancer may be particularly susceptible.
Wound myiasis can worsen symptom burden, and cause
psychosocial distress for both patients and their caregiv-
ers. Although little HPM-specific literature exists on this
topic, providers should have a working knowledge of the
risk factors and treatment modalities available to man-
age cutaneous myiasis while providing interdisciplinary
support for this complex condition, as timely management
can significantly improve the quality of life of affected
patients.
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